THE TREATMENT OF SEVERE ALLERGIC ASTHMA WITH OMALIZUMAB

Journal Title: Pulmonologija ir alergologija - Year 2018, Vol 2, Issue 2

Abstract

Omalizumab is effective for the treatment of severe allergic asthma irrespective of pre-treatment blood eosinophil count. Omalizumab decreases the rate of exacerbation, the dose of systemic and inhaled gliucocorticoids, increases the quality of life. Treatment with omalizumab safe, effectiveness long term, besides is the possibility to treat children.

Authors and Affiliations

Kristina Biekšienė

Keywords

Related Articles

EFFICACY OF OMALIZUMAB TREATMENT FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA

Background. Chronic spontaneous urticaria is defined as itchy hives, lasting for 6 and more weeks, with or without angioedema. Part of the patients do not have a response to a standard therapy with H1 antihistamines even...

EOSINOPHILS VIABILITY INCREASES AFTER THEIR INTERACTION WITH AIRWAY SMOOTH MUSCLE CELLS IN ASTHMA

Background. Viability of peripheral blood eosinophils are significantly lower than airway eosinophils. It may be assumed that direct contact between eosinophils and pulmonary structural cells increase eosinophils surviva...

RELVAR ELLIPTA SIGNIFICANTLY IMPROVED ASTHMA CONTROL IN SALFORD LUNG STUDY PATIENTS COMPARED WITH THEIR USUAL CARE

Salford Lung Study is an open-label, randomised, controlled, two-arm effectiveness trial at general practice clinics. In patients with symptomatic asthma and on maintenance inhaler therapy, initiation of a on...

THE ROLE OF TIOTROPIUM AND OLODATEROL COMBINATION IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Inhaled bronchodilators are the main treatment of chronic obstructive pulmonary disease and are recommended by Global Obstructive Lund Disease Initiative (GOLD). Long acting anti – muscarins (LAMA) and long acting β2 ago...

OMALIZUMAB: SEVERE ALLERGIC ASTHMA TREATMENT OPTION

Omalizumab is a monoclonal antibody against immunoglobulin E (IgE) which prevents free IgE from interacting with the high and low affinity IgE receptors on effector cells. Results of various studies prove...

Download PDF file
  • EP ID EP502753
  • DOI -
  • Views 116
  • Downloads 0

How To Cite

Kristina Biekšienė (2018). THE TREATMENT OF SEVERE ALLERGIC ASTHMA WITH OMALIZUMAB. Pulmonologija ir alergologija, 2(2), 156-160. https://europub.co.uk./articles/-A-502753